Skip to Main Content

Paper Details

Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia.
Leuk Res
0
2023
AML, ARLVD, Anthracycline, Anthracycline-related left ventricular dysfunction, JAK2, JAK2 mutation, acute myeloid leukemia, anthracycline, cardiovascular, coronary artery disease, diabetes mellitus, hyperlipidemia, hypertension, left ventricular dysfunction, myeloid mutations, patient, patients
Author NameAffiliation
Eric P WinerDana-Farber Cancer Institute
Robert Coleman LindsleyDana-Farber Cancer Institute
Daniel J DeAngeloDana-Farber Cancer Institute
Richard M StoneDana-Farber Cancer Institute
Marlise R LuskinDana-Farber Cancer Institute
  • 1 - 5

Datasets

Release 1.2